Showing 19,161 - 19,177 results of 19,177 for search '(( significant effects decrease ) OR ( significant ((a decrease) OR (step decrease)) ))', query time: 0.63s Refine Results
  1. 19161

    Data Sheet 6_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  2. 19162

    Data Sheet 9_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  3. 19163

    Data Sheet 11_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  4. 19164

    Data Sheet 3_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.pdf by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  5. 19165

    Data Sheet 8_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  6. 19166

    Data Sheet 5_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  7. 19167

    Data Sheet 15_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.pdf... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  8. 19168

    Data Sheet 10_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  9. 19169

    Data Sheet 13_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  10. 19170

    Data Sheet 4_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  11. 19171

    Data Sheet 7_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  12. 19172

    Data Sheet 14_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.pdf... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  13. 19173

    Data Sheet 2_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.pdf by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  14. 19174

    Data Sheet 12_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.zip... by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  15. 19175

    Data Sheet 1_Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease.pdf by Chutian Zhang (10732350)

    Published 2025
    “…Additionally, it significantly decreased the levels of ROS, the decline in MMP, and apoptosis rates in these cells.…”
  16. 19176

    Autophagy induced by mechanical stress sensitizes cells to ferroptosis by NCOA4-FTH1 axis by Chenyu Luo (12443535)

    Published 2025
    “…Additionally, low mechanics significantly diminishes NCOA4, pivotal in mediating FTH1 phase separation-induced ferritinophagy. …”
  17. 19177

    Supplementary data: Characterization of medical device randomized controlled trials with adaptive designs by Gui Su (128698)

    Published 2024
    “…The average annual number of adaptive RCTs per 1000 clinical trials was the highest (8.55 ± 11.65) during 2005–2010, reduced to 3.33 ± 2.35 during 2011–2016, and significantly decreased to 1.29 ± 0.85 during 2017–2024 (p = 0.011). …”